Cargando…

The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration

Capsid-like particle (CLP) displays can be used to enhance the immunogenicity of vaccine antigens, but a better understanding of how CLP vaccines are best formulated and delivered is needed. This study compared the humoral immune responses in mice elicited against two different vaccine antigens (a b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janitzek, Christoph M., Carlsen, Philip H. R., Thrane, Susan, Khanna, Vijansh M., Jakob, Virginie, Barnier-Quer, Christophe, Collin, Nicolas, Theander, Thor G., Salanti, Ali, Nielsen, Morten A., Sander, Adam F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915698/ https://www.ncbi.nlm.nih.gov/pubmed/33562114 http://dx.doi.org/10.3390/vaccines9020131

Ejemplares similares

A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine
por: Janitzek, Christoph M., et al.
Publicado: (2019)

Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems
por: Fredsgaard, Laurits, et al.
Publicado: (2021)

Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses
por: Janitzek, Christoph M., et al.
Publicado: (2016)

A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice
por: Thrane, Susan, et al.
Publicado: (2020)

A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
por: Thrane, Susan, et al.
Publicado: (2015)

Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature
por: Aves, Kara-Lee, et al.
Publicado: (2022)

Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
por: Prentoe, Jannick, et al.
Publicado: (2022)

Bacterial superglue enables easy development of efficient virus-like particle based vaccines
por: Thrane, Susan, et al.
Publicado: (2016)

A Comparison of Intramuscular and Subcutaneous Administration of LigA Subunit Vaccine Adjuvanted with Neutral Liposomal Formulation Containing Monophosphoryl Lipid A and QS21
por: Techawiwattanaboon, Teerasit, et al.
Publicado: (2020)

Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses
por: Poecheim, Johanna, et al.
Publicado: (2016)

Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators
por: Barnier-Quer, Christophe, et al.
Publicado: (2013)

Virus-like particle display of HER2 induces potent anti-cancer responses
por: Palladini, Arianna, et al.
Publicado: (2018)

Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
por: Younis, Sumera Y., et al.
Publicado: (2018)

Immunization with virus-like particles conjugated to CIDRα1 domain of Plasmodium falciparum erythrocyte membrane protein 1 induces inhibitory antibodies
por: Harmsen, Charlotte, et al.
Publicado: (2020)

Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned
por: Lemoine, Céline H., et al.
Publicado: (2021)

Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review
por: Nooraei, Soren, et al.
Publicado: (2023)

Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein
por: Bugli, Francesca, et al.
Publicado: (2014)

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens
por: Prentoe, Jannick, et al.
Publicado: (2021)

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
por: Fougeroux, Cyrielle, et al.
Publicado: (2021)

Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release
por: Poecheim, Johanna, et al.
Publicado: (2015)

Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis
por: Goksøyr, Louise, et al.
Publicado: (2022)

Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route
por: Vo, Trinh Phuong, et al.
Publicado: (2022)

Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA
por: Resende, Mafalda, et al.
Publicado: (2008)

Immunogenicity of Pigeon Circovirus Recombinant Capsid Protein in Pigeons
por: Stenzel, Tomasz, et al.
Publicado: (2018)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA
por: Andersen, Pernille, et al.
Publicado: (2008)

Changes in var gene mRNA levels during erythrocytic development in two phenotypically distinct Plasmodium falciparum parasites
por: Dahlbäck, Madeleine, et al.
Publicado: (2007)

Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA
por: Ditlev, Sisse B., et al.
Publicado: (2014)

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
por: Goksøyr, Louise, et al.
Publicado: (2022)

Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice
por: Zhao, Fu-jie, et al.
Publicado: (2022)

Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
por: Kreppel, Florian, et al.
Publicado: (2021)

Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions
por: Lavstsen, Thomas, et al.
Publicado: (2003)

Structure function analysis of P. falciparum VAR2CSA
por: Dahlbäck, Madeleine, et al.
Publicado: (2010)

Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
por: Salanti, Ali, et al.
Publicado: (2010)

HIV-1 capsid interacts with cytoskeletal-associated proteins for intracytoplasmic routing to the nucleus
por: Fernandez, Juliette, et al.
Publicado: (2013)

A DNA-Modified Live Vaccine Prime–Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus
por: Bernelin-Cottet, Cindy, et al.
Publicado: (2019)

Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae
por: Matthijs, Anneleen Marguerite Filip, et al.
Publicado: (2019)

Reduced Renal Colonization and Enhanced Protection by Leptospiral Factor H Binding Proteins as a Multisubunit Vaccine against Leptospirosis in Hamsters
por: Techawiwattanaboon, Teerasit, et al.
Publicado: (2019)

Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model
por: Hu, Hui, et al.
Publicado: (2009)

Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization
por: Sasaki, Eita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q9rtnn0gtrq53biltrc57esh82